comparemela.com

Latest Breaking News On - Yas holding healthcare division - Page 1 : comparemela.com

Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa

/PRNewswire/ Bioventure, a Dubai-based pharmaceutical company, Minapharm Pharmaceuticals, a Cairo-based pharmaceutical company, and MiGenTra GmbH, a.

Al qahirahUnited arab emiratesAl iskandariyahAshraf radwanWafik bardissiPrnewswire bioventureDina solimanLutz hilbrichMigentra gmbRobert wessmanMinapharm pharmaceuticalsNasdaq us stock exchangeBusiness development licensingGlobalone healthcare holdingYas holding healthcare divisionHealthcare division of yas holding

Minapharm Pharmaceuticals; MiGenTra GmbH: Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa

BERLIN, CAIRO and DUBAI, UAE, Nov. 30, 2022 /PRNewswire/ Bioventure, a Dubai-based pharmaceutical company, Minapharm Pharmaceuticals, a Cairo-based pharmaceutical company, and MiGenTra GmbH

Al qahirahUnited arab emiratesAl iskandariyahAshraf radwanWafik bardissiPrnewswire bioventureDina solimanLutz hilbrichMigentra gmbRobert wessmanMinapharm pharmaceuticalsNasdaq us stock exchangeBusiness development licensingGlobalone healthcare holdingYas holding healthcare divisionHealthcare division of yas holding

Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa

Download logoBioventure, a Dubai-based pharmaceutical company, Minapharm Pharmaceuticals, a Cairo-based pharmaceutical company, and MiGenTra GmbH

Al qahirahUnited arab emiratesAl iskandariyahAshraf radwanSarah wandreyWafik bardissiDina solimanMigentra gmbLutz hilbrichRobert wessmanMinapharm pharmaceuticalsMigentra press contactNasdaq us stock exchangeBusiness development licensingGlobalone healthcare holdingBusiness development strategic operations

Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement for the Commercializa

 BERLIN, Germany, CAIRO, Egypt and DUBAI, United Arab Emirates, November 29, 2022 / B3C newswire /  Bioventure, a Dubai-based pharmaceutical company, Minapharm Pharmaceuticals, a Cairo-based pharmaceutical company, and MiGenTra GmbH, a Berlin-based pharmaceutical company, announced today the signing of a.

Al qahirahUnited arab emiratesAl iskandariyahAshraf radwanWafik bardissiSarah wandreyDina solimanLutz hilbrichMigentra gmbRobert wessmanMinapharm pharmaceuticalsMigentra press contactNasdaq us stock exchangeBusiness development licensingGlobalone healthcare holdingBusiness development strategic operations

Bioventure Healthcare to expand production

The newly rebranded Bioventure Healthcare plans to expand the production capacity of its manufacturing plant by introducing new products such as oral solid tablets, capsules and sachets lines by 2023.

Ministry of healthUnited arab emiratesAl ittihadAbuz abyAshraf radwanEuropean union good manufacturing practicesNational industries parkWellpharma medical solutionsGlobalone healthcare holdingAl ittihad drug storeYas holding healthcare divisionTradearabia news serviceBioventure healthcareYas holdingHealthcare divisionGeltec healthcare

vimarsana © 2020. All Rights Reserved.